World Lifestyle Archives | Page 2 of 57 | Be Korea-savvy

Archive by category World Lifestyle

2017 Online Journalism Awards Winners Include Le Temps, The Washington Post and STAT

2017 Online Journalism Awards Winners Include Le Temps, The Washington Post and STAT

WASHINGTON, Oct. 11 (Korea Bizwire) — Superlative reporting on leaked data, prison reform and undue police force led coverage that garnered top honors for 29 media organizations Saturday night at the 2017 Online Journalism Awards, which closed the Online News Association Conference.  At the 17th annual awards dinner, emceed by host of WAMU and NPR’s [...]

ATPCO Opens Door to Bridge Labs to Fuel Airline Distribution Future

ATPCO Opens Door to Bridge Labs to Fuel Airline Distribution Future

DULLES, Va., Oct. 10 (Korea Bizwire) — ATPCO today announced the launch of ATPCO Bridge Labs. The platform will connect the unmatched airline fare, rule, and merchandising data of ATPCO with emerging and established companies in travel and technology to harness the powerful innovation taking place in airline distribution. Using ATPCO Bridge Labs as a [...]

VistaJet’s US Customer Base Trebles – Reinforcing Its Commanding Position in the Market

VistaJet’s US Customer Base Trebles – Reinforcing Its Commanding Position in the Market

LAS VEGAS, Oct. 9 (Korea Bizwire) — VistaJet, the first and only global aviation company, is delighted to announce a set of results that highlights the significant progress made in the US throughout the third quarter ending September 30, 2017. Driving the growth is the company’s flagship Program Membership, registering three times more clients year [...]

Medibio Enters Into an Agreement with Otsuka Pharmaceutical Development & Commercialization, Inc.

Medibio Enters Into an Agreement with Otsuka Pharmaceutical Development & Commercialization, Inc.

SYDNEY, Australia and MINNEAPOLIS, Oct. 8 (Korea Bizwire) —  Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), is a mental health technology company that has pioneered the use of objective biometrics to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions,  is pleased to announce it has entered into [...]

DRGT Announces Results of Phase I Study Expanding Clinical Utility of the Drug Sirolimus Utilizing the Company’s Novel Super-API Technology Platform

DRGT Announces Results of Phase I Study Expanding Clinical Utility of the Drug Sirolimus Utilizing the Company’s Novel Super-API Technology Platform

MSIDA, Malta, Oct. 05 (Korea Bizwire) — DRGT, a specialty pharmaceutical company, today announced the results of its Phase I study of DRGT18-2, a novel formulation of Sirolimus (Rapamune®), originally a Pfizer product approved by the FDA. Sirolimus, as developed by Pfizer and approved by the FDA, initially failed to achieve sufficient therapeutic effect in [...]

The Graduate Management Admission Council Welcomes Three New Business Schools to Its Global Membership

The Graduate Management Admission Council Welcomes Three New Business Schools to Its Global Membership

RESTON, Va., Oct. 4 (Korea Bizwire) — The Graduate Management Admission Council (GMAC), a nonprofit organization of leading graduate business schools, is pleased to welcome three new graduate business schools to its membership. The addition of McGill University, Desautels Faculty of Management (Canada); University of Mannheim, Mannheim Business School (Germany); and University of St. Gallen [...]

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

TEL-AVIV, Israel and RALEIGH, N.C., Oct. 3 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced positive top-line results from the Phase II [...]

Integra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & Johnson

Integra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & Johnson

PLAINSBORO, N.J., Oct. 2 (Korea Bizwire) — Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, announced today that it has completed the previously announced acquisition of the Johnson & Johnson Codman Neurosurgery business for approximately $1.045 billion less customary adjustments, enhancing Integra’s position as a leading global provider of neurosurgical products. “The [...]

NRT and Sightline Announce Exclusive Agreement with Kony to Create the Next Generation Digital Platform for the Resort Casino Industry

NRT and Sightline Announce Exclusive Agreement with Kony to Create the Next Generation Digital Platform for the Resort Casino Industry

LAS VEGAS, Oct. 2 (Korea Bizwire) — NRT Technology Corp. (“NRT”) a leading provider of integrated ticket redemption and payment services to global casino operators, and Sightline Payments (“Sightline”), developers of the disruptive Play+ platform that’s powering the next generation of cashless and mobile gaming payment solutions, announced today an exclusive agreement with Kony, Inc., [...]

RedHill Biopharma Accelerates RHB-104 Phase III Study in Crohn’s Disease with Top-Line Results Expected Mid-2018

RedHill Biopharma Accelerates RHB-104 Phase III Study in Crohn’s Disease with Top-Line Results Expected Mid-2018

TEL-AVIV, Israel and RALEIGH, N.C., Oct. 2 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that the Company has accelerated the timelines [...]